Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • J Cell Mol Pharmacol 2023, Vol 7(4): 4
  • DOI: 10.4172/jcmp.1000167

Rising to the Challenge Confronting Drug Resistance in the Modern Healthcare Landscape

Hattersley Larralde*
Department of Pathology and Laboratory Medicine, University of British Columbia, Canada
*Corresponding Author : Hattersley Larralde, Department of Pathology and Laboratory Medicine, University of British Columbia, Canada, Email: hattersley.larralde@gmail.com

Received Date: Jul 20, 2023 / Published Date: Aug 18, 2023

Abstract

Drug resistance has emerged as a formidable challenge in modern healthcare, posing significant threats to the effectiveness of treatments across various medical disciplines. This paper examines the multifaceted problem of drug resistance, encompassing its molecular mechanisms, epidemiological factors, and clinical implications. We delve into the pivotal role of microbial organisms, such as bacteria and viruses, in driving antibiotic and antiviral resistance, as well as the genetic and adaptive processes that underlie this phenomenon. Furthermore, we explore how drug resistance extends beyond infectious diseases to encompass cancer and other non-communicable diseases, complicating therapeutic strategies. The socio-economic dimensions of drug resistance are also considered, highlighting the economic burdens and healthcare disparities it engenders. In response, this paper proposes a comprehensive approach involving enhanced surveillance, novel drug development, optimized treatment protocols, and public education. By rising to the challenge of drug resistance, the modern healthcare landscape can safeguard the efficacy of existing treatments and ensure better health outcomes for patients worldwide.

Citation: Larralde H (2023) Rising to the Challenge Confronting Drug Resistance in the Modern Healthcare Landscape. J Cell Mol Pharmacol 7: 167. Doi: 10.4172/jcmp.1000167

Copyright: © 2023 Larralde H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top